PeptiDream bags over $3 billion in deals with Merck and Eli Lilly for delivering Novel Peptide Drug Conjugates
PeptiDream to collaborate with Merck and Eli Lilly for the discovery and development of Novel Peptide Drug Conjugates
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
PeptiDream to collaborate with Merck and Eli Lilly for the discovery and development of Novel Peptide Drug Conjugates
Aurobindo Pharma announced that its fully-owned subsidiary, Eugia Pharma Specialities, received final approval from FDA to make and market Azacitidine injection for cancer.
China tore on to Covid-19 travel restrictions imposed on travellers from Beijing by the US and EU nations and stated it will take.
A coin-sized implant device has the potential to treat Type 1 diabetes, researchers claim.
A nanoparticle treatment has "cured" mice that had a genetic arthritis condition, according to Scripps Research, a nonprofit US medical research institution.
Bharat Biotech, an Indian developer of vaccines for infectious diseases, will roll out its nasal Covid-19 vaccine for patients above 18 years in.
The WHO has told Chinese officials to regularly share specific and real-time data on the Covid-19 pandemic as Beijing eases the world's strictest.
The EU will take joint measures to thwart the spread of the Covid-19 virus as China eases its strict zero-Covid policy and tight.
Drug regulators started investigating Marion Biotech after Uzbekistan alleged 18 children died in Samarkand city following the consumption of cough syrup made by.
A US court dismissed all claims against Dr. Reddy's Laboratories Inc., a wholly-owned subsidiary, in an antitrust complaint related to the cancer drug.